76 related articles for article (PubMed ID: 16399850)
1. Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity.
Lewis MA; Hunihan L; Franco D; Robertson B; Palmer J; Laurent DR; Balasubramanian BN; Li Y; Westphal RS
Mol Pharmacol; 2006 Apr; 69(4):1396-404. PubMed ID: 16399850
[TBL] [Abstract][Full Text] [Related]
2. Cyclic-AMP response element-based signaling assays for characterization of Trk family tyrosine kinases modulators.
Zhang J; Chen D; Gong X; Ling H; Zhang G; Wood A; Heinrich J; Cho S
Neurosignals; 2006-2007; 15(1):26-39. PubMed ID: 16837782
[TBL] [Abstract][Full Text] [Related]
3. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
Lambert WS; Clark AF; Wordinger RJ
Mol Vis; 2004 Apr; 10():289-96. PubMed ID: 15105791
[TBL] [Abstract][Full Text] [Related]
4. Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo.
Lin MI; Das I; Schwartz GM; Tsoulfas P; Mikawa T; Hempstead BL
Dev Biol; 2000 Oct; 226(2):180-91. PubMed ID: 11023679
[TBL] [Abstract][Full Text] [Related]
5. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
6. Dok5 is substrate of TrkB and TrkC receptors and involved in neurotrophin induced MAPK activation.
Shi L; Yue J; You Y; Yin B; Gong Y; Xu C; Qiang B; Yuan J; Liu Y; Peng X
Cell Signal; 2006 Nov; 18(11):1995-2003. PubMed ID: 16647839
[TBL] [Abstract][Full Text] [Related]
7. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development.
Bartkowska K; Paquin A; Gauthier AS; Kaplan DR; Miller FD
Development; 2007 Dec; 134(24):4369-80. PubMed ID: 18003743
[TBL] [Abstract][Full Text] [Related]
8. NT-3 modulates BDNF and proBDNF levels in naïve and kindled rat hippocampus.
Ullal GR; Michalski B; Xu B; Racine RJ; Fahnestock M
Neurochem Int; 2007 May; 50(6):866-71. PubMed ID: 17462792
[TBL] [Abstract][Full Text] [Related]
9. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways of the early differentiation of neural stem cells by neurotrophin-3.
Lim MS; Nam SH; Kim SJ; Kang SY; Lee YS; Kang KS
Biochem Biophys Res Commun; 2007 Jun; 357(4):903-9. PubMed ID: 17466268
[TBL] [Abstract][Full Text] [Related]
11. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
12. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
Pillai A; Veeranan-Karmegam R; Dhandapani KM; Mahadik SP
J Neurochem; 2008 Nov; 107(4):941-51. PubMed ID: 18786174
[TBL] [Abstract][Full Text] [Related]
13. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Traver S; Marien M; Martin E; Hirsch EC; Michel PP
Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical evidence for the presence and location of the neurotrophin-Trk receptor family in adult human preovulatory ovarian follicles.
Seifer DB; Feng B; Shelden RM
Am J Obstet Gynecol; 2006 Apr; 194(4):1129-34; discussion 1134-6. PubMed ID: 16580310
[TBL] [Abstract][Full Text] [Related]
15. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
16. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease.
Diarra A; Geetha T; Potter P; Babu JR
Biochem Biophys Res Commun; 2009 Dec; 390(3):352-6. PubMed ID: 19818333
[TBL] [Abstract][Full Text] [Related]
17. Trk kinase inhibitors as new treatments for cancer and pain.
Wang T; Yu D; Lamb ML
Expert Opin Ther Pat; 2009 Mar; 19(3):305-19. PubMed ID: 19441906
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma.
Nassenstein C; Dawbarn D; Pollock K; Allen SJ; Erpenbeck VJ; Spies E; Krug N; Braun A
J Allergy Clin Immunol; 2006 Sep; 118(3):597-605. PubMed ID: 16950277
[TBL] [Abstract][Full Text] [Related]
19. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
20. Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation.
De Vries L; Finana F; Cachoux F; Vacher B; Sokoloff P; Cussac D
Cell Signal; 2010 Jan; 22(1):158-65. PubMed ID: 19781635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
